Adjustment Disorder

REKINDLE STUDY

The REKINDLE study is exploring whether an investigational psychedelic treatment may support improved mental health for people experiencing depression and anxiety related to adjustment disorder following a major medical illness.

To be eligible to participate, the participant must be:

• Between 18 and 80 years old
• Diagnosed with cancer (stages 1-4), or other serious conditions such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's disease (PD), or idiopathic pulmonary fibrosis (IPF)
• Experiencing symptoms of depression with or without anxiety and feeling overwhelmed for at least four weeks

For more information about this research study, please contact:

Center for Psychopharmacologic Research and Treatment
at CPRTResearchOffice@umassmed.edu or 508-856-1882

Local IRB docket number: STUDY00002791
Advarra IRB study number: Pro00086238
ClinicalTrials.gov ID: NCT07002034

(PI: ROTHSCHILD, ANTHONY)